Discussione tra esperti
Stato della tecnologia OCT – La sua direzione e considerazioni principali per il tuo ambulatorio retinico
Esperti clinici e del settore discutono la storia e il futuro della tecnologia OCT
15 maggio 2020
· 65 MIN VISIONE
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original.image_file.100.100.file/eric_w_schneider.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg"})
Autore
Eric W. Schneider, MD
Tennessee Retina
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.100.100.0,34,319,353.file/headshot-ar1.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg"})
Autore
Angelo Rago
Carl Zeiss Meditec, Inc.
RIEPILOGO
L’evoluzione e il futuro della tecnologia OCT, inclusa la Swept Source OCT e la SD-OCT ad alte prestazioni
Nel corso di questo webinar registrato, lo specialista della retina Eric Schneider, MD, Tennessee Retina e Angelo Rago, responsabile della diagnostica oftalmica di ZEISS, danno uno sguardo all’evoluzione della tecnologia OCT da quando ZEISS ha introdotto la tomografia a coerenza ottica quasi quindici anni fa. Da allora la tecnologia è diventata uno standard di cura in tutti i tipi di studi medici ed è cresciuta con l’angiografia OCT e la Swept Source OCT. Secondo Rago, è importante che i medici comprendano le tendenze di adozione della tecnologia, in particolare la curva di adozione dell’OCT, al momento di considerare le tecnologie nuove ed emergenti.
Questa discussione valuta anche:
- Il ruolo della Swept Source OCT
- OCT ad alte prestazioni: come cambiare il tuo lavoro in ambulatorio
- Aspetti da considerare per l’acquisto odierno di una OCT